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ABSTRACT 
 
Background : Bardet-Biedl syndrome (BBS) is a genetically heterogeneous, multisystemic disorder 
characterized by progressive retinal dystrophy, obesity, hypogenitalism, learning difficulties, renal 
abnormalities and postaxial polydactyly, with only the last two antenatally observable. BBS is 
inherited as an autosomal recessive disorder and 14 genes have been identified to date (BBS1-
BBS14). In addition, a complex digenic inheritance has been established in some families. 
Mutations of the BBS10 gene on chromosome 12q21.2 account for 20% of BBS cases.  
Methods: Given the fact that mutations in BBS genes have already been found in Meckel-like 
fetuses, and in light of the major contribution of BBS10 to BBS, we sequenced the BBS10 gene in 
20 fetal cases and a child diagnosed antenatally presenting characteristic renal anomalies and 
polydactyly, but without biliary dysgenesis.  
Results: We identified recessive mutations at the BBS10 locus in 5 cases, 4 fetuses and a child. 
Interestingly, one of them had situs ambiguus, a rare feature in BBS. In the child, BBS genes 
screening identified a heterozygous BBS6 nonsense mutation in addition to the homozygous BBS10 
mutation, in accordance with the suggested multigenic inheritance of the disease.  
Conclusions: These results confirm that BBS is underdiagnosed antenatally, and should 
systematically be suspected in fetuses with severe cystic kidneys leading to oligoamnios and fetal or 
perinatal death. Moreover, this study confirms the high frequency of BBS10 mutations and 




 Congenital anomalies of the kidney and urinary tract (CAKUT) in association with non-
renal anomalies are found in more than 200 syndromes. CAKUT represent a broad range of 
disorders that result from abnormal embryogenic renal development due to parenchymal 
malformations, abnormalities in migration of organ primordia, or abnormalities in the developing 
collecting system. Malformations of the renal parenchyme lead to failure of normal nephron 
development in terms of renal dysplasia, renal agenesis, renal tubular dysgenesis, and polycystic 
renal diseases. Cystic kidneys can be detected on prenatal ultrasonography, particularly during the 
second trimester, and can cause fetal death in utero by oligohydramnios or associated anomalies. 
This feature, visible on ultrasound, can appear isolated, as in polycystic kidney disease, or 
associated with multiple congenital anomalies. Accurate diagnosis in antenatal cases is important to 
evaluate prognosis, and to propose adequate management of the pregnancy and genetic 
counselling.1  
 
 Bardet-Biedl syndrome (BBS, OMIM 209900), initially described by Bardet in 1920 and 
Biedl in 1922, is an autosomal recessive multisystemic disorder characterized by progressive retinal 
dystrophy, postaxial polydactyly, obesity, hypogenitalism, learning difficulties and renal 
abnormalities. In addition to the major diagnostic features, multiple other manifestations have also 
been documented.2, 3 These include diabetes mellitus, neurological signs, behavioural traits, facial 
dysmorphism, dental anomalies, heart disease, and hepatic fibrosis.3 Prevalence rates in North 
America and Europe range from 1:125,000 to 1:175,000 live births.2 Because of the late onset of 
symptoms, the diagnosis of BBS is usually made during childhood and certainly underdiagnosed 
antenatally. At birth, suggestive features are polydactyly, renal abnormalities, genital or heart 
malformations. However, it has been shown that a severe clinical presentation of BBS including 
lethal cystic kidneys disease can mimic Meckel Syndrome (MKS, OMIM 249000). 4 
 
 Fourteen BBS genes have been identified to date (BBS1-BBS14). Two of these genes, MKS1 
(BBS13) and CEP290 (BBS14) are usually involved in Meckel Syndrome and Joubert Syndrome, 
and may have a potential epistatic effect with known BBS-associated loci.5 BBS genes encode 
proteins involved in the development and function of primary cilia.6 BBS therefore became a model 
to help understand of ciliary signalling mechanisms.7 This discovery of other disorders caused by 
similar ciliary structural and signalling defects supported the concept of “ciliopathies”8, inherited 
diseases resulting from ciliary dysfunction.9 Ciliopathies comprise phenotypically overlapping 
disorders 10 with renal malformations (renal dysplasia and cystic kidney disease) being one of the 
more common unifying features11, 12 and a variable degree of polydactyly, obesity, hypogonadism, 
central nervous anomalies, retinitis pigmentosa and laterality defects. 
 
 Mutations in one of the 14 known BBS genes are found in approximately 80% of BBS 
cases.7 In addition, a complex digenic inheritance has been established in some families, where 
three mutations at two BBS loci are necessary for the expression of the disease.8, 13-15. The BBS10 
gene, also called FLJ23560, identified in 2006 by Stoetzel et al., accounts for 21% of BBS cases.16 
BBS10 encodes a vertebrate-specific chaperonin-like protein which interacts with bbs1, 4 and 6 in 
zebrafish16 and is localised at the basal body of the primary cilium.17 Recent studies have 
demonstrated the role for the three chaperonin-like BBS proteins (BBS10 with BBS6 and BBS12) 
in forming a complex of CCT/TRiC family chaperonins which then mediates BBSome assembly, a 
structure which transports vesicles within the cilium.18 Given the phenotypic overlap of ciliopathies, 
the fact that mutations in BBS genes have already been found in Meckel-like fetuses, and the major 
contribution of BBS10 to BBS, we screened for mutations in BBS10 in 20 fetuses and a child 
referred for cystic kidneys, polydactyly and/or a central nervous system anomaly but without the 




MATERIAL AND METHODS 
 
We analysed the BBS10 gene in 20 cases with cystic kidneys diagnosed antenatally and 
polydactyly, but without occipital encephalocele or biliary dysgenesis. Parental consents for the 
genetic study were obtained in all cases. In all but one, pregnancy was terminated in accordance 
with French legislation either because of the severe renal dysfunction (oligohydramnios) or because 
of its association with another anomaly. Chromosome analysis and clinicopathological examination 
were performed in all cases except case one, where parents declined pregnancy termination after 
genetic counselling. Clinical and histological features of mutated cases are summarized in Table 1.  
 Genomic DNA was extracted from frozen fetal tissues or from a blood sample in case 1, 
and from parents. Primers used were previously described.16 All amplifications were performed 
under the same conditions, using a touchdown protocol consisting of denaturation for 30s at 96°C, 
annealing for 30s at a temperature ranging from 64°C to 50°C (decreasing 1° during 14 cycles, then 
20 cycles at 50°) and extension at 72°C for 30s. PCR products were treated with ExoSAP-IT (USB, 
Affymetrix). Both strands were sequenced with the appropriate primer and the BigDye terminator 
cycle sequencing kit (Applied Biosystems, Foster City, CA) and analyzed on ABI3130 automated 
sequencers (Applied Biosystems, Foster City, CA). Segregation of the identified mutations was 
investigated in parents when available. Mutation numbering is based on cDNA sequence with a ‘c.’ 
symbol before the number, where +1 corresponds to the A of ATG translation codon (codon 1) of 





We found BBS10 mutations in five cases, four fetuses and a child. Clinical and mutation data are 
presented in Table 1.  
Table 1: Clinical data and BBS10 mutations 
 
Case Age  Kidney PD Other Nucleotide 
alterations Exon 
Predicted 
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Foetal cases: age is given in gestational weeks. PRF: progressive renal failure, MKS-like: cystic kidneys similar to that 
observed in Meckel syndrome, PD: polydactyly, 4L: 4 limbs, UL: upper limbs, LL: lower limbs, RH: right hand, RF: 
right foot, LF: left foot, PRD: progressive retinal dystrophy. 
 
Case 1 is now a twenty year-old young woman, seen antenatally because of the association of 
enlarged hyperechogenic kidneys and postaxial polydactyly, and described previously (case 7 of 
Karmous-Benailly).4 After birth, the size of the kidneys decreased to normal while progressive renal 
failure appeared. Obesity started at 3 years and an electroretinogram examination established the 
diagnosis of BBS. At 12 years of age, vision was normal. Direct sequencing of the BBS10 gene 
found a homozygous T insertion in exon 2, at residue 91, leading to premature protein termination 
(c.271dupT, p.Cys91LeufsX5). Moreover, previous sequencing of BBS1 to BBS8 genes had 
revealed a heterozygous mutation in exon 3 of the BBS6 gene: p.Arg139X.4  
 
Case 2 was a 23-weeks old female fetus. The pregnancy was terminated because of severe cystic 
kidneys and anamnios. Autopsy revealed enlarged kidneys with nonetheless normal 
nephronogenesis, containing multiple thin-walled cysts along nephron segments and collecting 
ducts, and demonstrating a gradient in the size of cysts from periphery to center,. The parenchyme 
was otherwise normal, without metaplasic cartilage. The kidneys were therefore histologically 
similar to those observed in Meckel syndrome, and termed “Meckel-like” kidneys (Fig 1A). The 
fetus had also right hand and foot hexadactyly. No other abnormality was found, in particular no 
liver anomaly (Fig 1B). Molecular studies found a homozygous frameshift mutation in exon 2 
c.271dupT, p.Cys91LeufsX5. 
 
Case 3 was a 26-week old female fetus presenting enlarged hyperechogenic kidneys and 
hexadactyly of all four limbs. Meckel or Bardet-Biedl syndromes were evoked antenatally. After 
genetic counselling, parents asked for termination of pregnancy. Autopsy showed facial 
dysmorphism with a round face, hypertelorism, small flattened nose, micro-retrognathism and small 
ears, characteristic of Potter’s dysmorphism. Examination confirmed post-axial hexadactyly and 
cystic kidneys. Histological examination of the kidneys showed "Meckel-like" cyst size and number 
augmentation from the cortex to the medulla (Fig 1C). Lesions were moderate with persistence of 
cortico-medulary differentiation and sub-capsular nephrogenesis. The liver was histologically 
normal (fig 1D). Direct sequencing of BBS10 found compound heterozygous mutations. The fetus 
carried a T insertion at residue 91 leading to premature termination c.271dupT, p.Cys91Leufs*5 
(fig 1I) inherited from his mother and a 2 base pair deletion paternally inherited: 
c.1044_1045delTT, p.Pro350Ilefs*11 (fig 1J). 
 
Case 4 was a 21-weeks old male fetus. The pregnancy was terminated because of the association of 
cystic kidneys and situs ambiguus. Examination of this fetus found a facial dysmorphism with 
retrognatism and hypoplastic nasal bone characteristic of Potter sequence. There were postaxial foot 
polydactyly, pulmonary artery stenosis, and situs ambiguus where the stomach and spleen were 
localized on the right side with polysplenia. The pancreas was hypoplasic with absence of the tail. 
Histological examination of the kidneys showed Meckel-like cyst size and number augmentation 
from the cortex to the medulla (Fig 1E). Pancreatic ducts were slightly dilated. There were no brain 
or liver (Fig 1F) anomalies. Direct sequencing of BBS10 found two heterozygous mutations: a 
missense mutation c.273C>G, p.Cys91Trp (fig 1K) inherited from his mother and a TT deletion in 
exon 2 c.1044-1045delTT, p.Pro350Ilefs*11.  
  Case 5 was a 22 week female fetus presenting Meckel-like cystic kidneys (fig 1G), lower 
limb postaxial polydactyly and a Potter sequence with dysmorphism and contracted limbs. The liver 
was normal (Fig 1H). A previous pregnancy was terminated because of cystic kidneys and 
hexadactyly 11 years ago. We identified two heterozygous mutations: a maternal missense mutation 
c.185A>G p.His62Arg located in exon 1 (Fig 1L) and the recurrent c.271dupT, Cys91Leufs*5 
inherited from the father.  
 Among the 15 other cases in this series, eight had mutations in another BBS gene, namely 
BBS2 (3 cases), BBS4 (2 cases), BBS6 (2 cases) and BBS7 (1 case), and six of them have been 
reported previously.4  In addition, two fetuses within this series had agenesis of the cerebellar 
vermis, and in these, mutations were found in the CEP290 gene (NPHP6/MKS4), where biliary 
dysgenesis is known to potentially be absent. These two cases have also been described previously 
(cases 27 and 29).20 In the five remaining cases, all with similar Meckel-like kidney histology, 
polydactyly, but without biliary dysgenesis or brain malformations, no BBS gene mutations have 




Genetic screening in the cohort 
 The most characteristic diagnostic criteria for BBS, such as obesity and retinal anomalies, 
appear postnatally. Only the renal abnormalities, congenital heart defect, genital anomalies and 
polydactyly can be detected antenatally. In particular, enlarged and undifferentiated hyperechogenic 
kidneys on prenatal ultrasonography may suggest the diagnosis of BBS.21 A previous study showed 
that renal histological anomalies in BBS fetuses can be very comparable to those observed in 
Meckel Syndrome.4 However, liver histological anomalies included hepatic fibrosis but not biliary 
dysgenesis. Based on our previous analysis of BBS genes in antenatal cases, and the major 
contribution of BBS10 to BBS, we focused on a series of cases with cystic kidneys and polydactyly 
but no biliary dysgenesis to evaluate the contribution of BBS10 to this association. BBS10 mutations 
were found in 5/20 cases, demonstrating that BBS10 mutations are also observed in the lethal form 
of the disorder and that the c.271dupT, p.Cys91Leufs*5 mutation is a major contributor to the fetal 
form as well. Overall, 13/20 fetuses carried BBS gene mutations, further highlighting the recognized 
clinical variability that characterizes Bardet-Biedl syndrome (BBS). This frequency confirms that 
BBS can present as a perinatal, even lethal form, and suggests that the combination of renal 
malformation and polydactyly alone can be highly predictive of BBS. 
 
BBS10 mutated alleles and oligogenism 
 The same c.271dupT, p.Cys91Leufs*5 was found at the homozygous state in two non 
consanguineous and unrelated cases (cases 1 and 2), and represented 6/10 of the mutated alleles in 
our series. This is in accordance with the previous reports, where missense and truncating BBS10 
mutations have been found in 21% of BBS patients, the p.Cys91Leufs*5 change accounting for 
46% of the mutant alleles in the report of Stoetzel.16 This recurrent mutation is therefore the cause 
of the major contribution of BBS10 to the disease. Whether this mutation represents an ancient 
allele or a mutational hotspot has been debated, but the second hypothesis is favoured because of its 
identification in populations of various origins. Interestingly, unrelated cases 3 and 4 were 
compound heterozygous for BBS10 mutations, both carrying the same c.1044_1045delTT, 
p.Pro350Ilefs*11 mutation. This mutation has also been reported twice by Stoetzel et al. among the 
118 BBS10-mutated alleles in their series.16  
 In case 1, in addition to the homozygous BBS10 mutation, a heterozygous nonsense BBS6 
mutation was observed, in accordance with the suggested oligogenic inheritance of BBS. Indeed, in 
some families, three mutations at two loci are necessary to cause this disease.13, 14 Such 
observations provide a clue to the clinical variability of BBS8, 13, since in some families, two 
mutations at one locus have been sufficient to cause BBS, but a third mutation at another locus has 
been found in a more severely affected sib.8, 13 Moreover, a single gene can have either a causal or a 
modifying role in the disease.14 The ability of each BBS locus to modify the phenotypic expression 
of mutations in another BBS gene first suggested they are part of a same multiproteic complex, 
which has been demonstrated since by the identification of at least seven BBS proteins within a 
complex known as the BBSome, involved in ciliary protein trafficking22 Moreover, BBS6, BBS10, 
and BBS12 form a complex and are involved in BBSome assembly.18 The complex inheritance is 
relevant in light of genetic counselling and the explanation of variable expressivity. BBS6 is more 
often associated with oligogenic inheritance than the other BBS genes, as heterozygous mutations 
are the most frequent.8 
   
BBS10 phenotype 
 The clinical presentation of these five cases is consistent with previously described antenatal 
cases of BBS. In particular, no brain anomalies were found. One of our cases, Case 4, presented 
other features, namely situs ambiguous with polysplenia, pancreatic hypoplasia (absence of the tail) 
and pulmonary artery stenosis.  
 Other studies of BBS have described less frequent clinical signs, including laterality defects 
such as situs inversus in a few cases 23, 24. Ansley described 3 affected siblings with a homozygous 
3 bp deletion in the BBS8 gene.6 One of the siblings had complete situs inversus, pointing to 
variable expressivity of this feature. Moreover, Yen et al. demonstrated the implication of BBS 
genes in lateralization using knockdown zebrafish for the homologues of six human BBS genes, 
BBS2, 4, 5, 6, 7 and 8. The result is a disruption in Kuppfer’s vesicle, a ciliated organ playing a role 
in lateralization during embryogenesis.25 Deffert et al. proposed that situs inversus could be 
considered to be a minor criterion for BBS. However, this criterion is a rare but non-specific feature 
of many ciliopathies. 
 
Pleiotropic effect of ciliopathies : common mechanisms 
 The clinical phenotype of BBS is extremely variable and overlaps with other ciliopathies. 
There is also a genetic overlap, as the same gene mutations can be involved in different 
ciliopathies.5, 20, 26-28 Common features can be explained by common pathways, protein interactions, 
or multi-subunit complexes.12, 28 Primary cilia are present in numerous cell types and are involved 
in many cellular functions as cell polarity, chemosensation and mechanosensation, intercellular 
junctions’ formation, cell-cell contacts and interactions with the extracellular environment.29 
Pleiotropic features of ciliopathies are explained by the interference with signalling pathways 
necessary for embryonic development of organ primordia. Components of the ciliary signaling 
machinery that have been identified include ligands and effectors of the Hedgehog30, Wnt31, and 
Platelet-Derived Growth Factor Receptor32 signaling pathways. Following signal reception, ciliary 
transduction controls the balance between cellular differentiation, cell division and apoptosis 
through the regulation of such key developmental pathways.33 
 
Genotype - phenotype correlations in ciliopathies 
 While there is a clinical and genetic overlap between ciliopathies, differences in severity can 
be explained by the nature of the mutation itself, for some genes. For example, Delous et al. showed 
that while RPGRIP1L missense mutations lead to JBS, truncating mutations lead to MKS.28, 34 A 
strong genotype-phenotype correlation was also shown for the CC2D2A gene (JBS9, MKS6).35 
These data suggest that the two phenotypes represent a continuum in the spectrum of a single 
disorder. Leitch et al. showed that hypomorphic mutations in the MKS1 gene can be associated with 
BBS, while, to date, only MKS1 truncating mutations have been found in MKS fetuses.5 Other 
MKS genes may act as modifiers or be directly implied in digenic transmission.5 Therefore, in other 
instances, when no evident genotype-phenotype correlations are found, clinical variability might be 
explained by the total mutational load in ciliopathy genes, as suggested by the oligogenic 
inheritance in Joubert/MKS, nephronophthisis36 and retinal degeneration of ciliopathies.37  
  
Conclusion 
 This study suggests a high frequency of BBS10 mutations in the severe antenatal and lethal 
form of BBS, a frequency also observed in postnatal cases. Overall, previous analyses of BBS1-8 
genes and the new data brought by this study strongly support the conclusion that the association of 
renal anomalies and polydactyly, without biliary dysgenesis or brain anomalies, can be highly 
predictive of Bardet Biedl before birth (13/18, 70%). One-fifth of BBS cases still remain 
unaccounted for by mutations in the 14 loci described to date. Our data support the existence of 
other, yet unidentified, BBS genes to explain our failure to find mutations in certain suggestive 
antenatal cases. The identification of BBS genes and the delineation of a fetal phenotype of BBS has 
improved the molecular diagnosis of lethal cystic kidney disease before birth and allows vastly 
improved genetic counselling for concerned families. 
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LEGENDS OF FIGURES 
 
Figure 1: A-H: Histological sections of kidney (A, C, E, G) and liver (B, D, F, H) of four fetuses 
carrying BBS10 mutations. The four cases show kidney anomalies usually found in Meckel 
syndrome with normal nephrogenesis, thin-walled cysts along various nephron segments and 
collecting ducts, and a gradient in the size of cysts from the cortex to the medulla. The parenchyme 
was otherwise normal without metaplasic cartilage. There is no biliary dysgenesis. I-L: Sequence 
chromatograms: Sequence traces from cases 1 to 5: c.271dupT; p.Cys91LeufsX5 (I), c.1044-
1045delTT; p.Pro350Ilefs*11 (J), c.273C>G; p.Cys91Trp (K) and c.185A>G; p.His62Arg (L). 

